380 related articles for article (PubMed ID: 19370598)
1. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD004289. PubMed ID: 19370598
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
[TBL] [Abstract][Full Text] [Related]
3. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Shrivastava R
Cochrane Database Syst Rev; 2004 Oct; (4):CD004289. PubMed ID: 15495097
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
[TBL] [Abstract][Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for dialysis patients.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
[TBL] [Abstract][Full Text] [Related]
6. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
[TBL] [Abstract][Full Text] [Related]
7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
[TBL] [Abstract][Full Text] [Related]
8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
[TBL] [Abstract][Full Text] [Related]
10. Lipid-lowering agents for nephrotic syndrome.
Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
[TBL] [Abstract][Full Text] [Related]
11. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
12. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
[TBL] [Abstract][Full Text] [Related]
13. Statins for the primary prevention of cardiovascular disease.
Taylor F; Ward K; Moore TH; Burke M; Davey Smith G; Casas JP; Ebrahim S
Cochrane Database Syst Rev; 2011 Jan; (1):CD004816. PubMed ID: 21249663
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
Strippoli GF; Navaneethan SD; Johnson DW; Perkovic V; Pellegrini F; Nicolucci A; Craig JC
BMJ; 2008 Mar; 336(7645):645-51. PubMed ID: 18299289
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D compounds for people with chronic kidney disease not requiring dialysis.
Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
Cochrane Database Syst Rev; 2009 Oct; (4):CD008175. PubMed ID: 19821446
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.
Rabindranath KS; Adams J; Ali TZ; MacLeod AM; Vale L; Cody J; Wallace SA; Daly C
Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD006515. PubMed ID: 17443624
[TBL] [Abstract][Full Text] [Related]
17. Treatment for peritoneal dialysis-associated peritonitis.
Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
[TBL] [Abstract][Full Text] [Related]
18. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
Strippoli GF; Navaneethan SD; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
[TBL] [Abstract][Full Text] [Related]
20. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
Smart NA; Dieberg G; Ladhani M; Titus T
Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]